Novel transcript, antisense to tropomodulin 3

This is a non-coding RNA transcript annotated as antisense to the TMOD3 gene. Its sequence is complementary to the protein-coding TMOD3 gene, potentially regulating TMOD3 expression via antisense mechanisms such as RNA interference or transcript stability. There are no published experimental data on its function, disease relevance, or pharmacological targeting as of September 2025. Such transcripts are commonly annotated in genome databases; however, they are typically not considered therapeutic targets unless robust experimental validation demonstrates a role in disease or drug modulation[4].

Other names

Novel transcript, antisense to TMOD3